Oncotarget is a medical journal that covers research on oncology and associated fields. Readers can access the peer-reviewed journal online, without having to make any subscription. Oncotarget was first published in 2010. Over the last six years, it has continued to gain popularity among medical professionals. Impact Journals publishes the periodical. Mikhail Blasgosklonny and Andrei V. Gudkov are the journal’s editors-in-chief. The two scientists are both from the Roswell Park Cancer Institute.
With the increasing popularity of Oncotarget, the company has decided to increase the scope of its coverage. The journal is now accepting topics beyond oncology. To this end, it has launched different sections that will aid in increasing the number of topic covered. Some of the sections include Gerotarget and Aging, Immunology and Microbiology, Endocrinology, Neuropathology and Neuroscience, and Cardiology. There are also sections on Metabolism, Pharmacology, and Cell & Mol Biology. The reorganization of the journal will help in attracting more readers and contributors.
Oncotarget enjoys good impact factor. The first impact factor data released was included in the journal in 2011. ISI/Thomson JCR gave the journal a rating of 4.784. The following year saw the ratings jump to 6.636. This is the highest value that Oncotarget has received to date. However, the total cites have increased from a paltry 493 in 2011 to 10452 in 2016. Oncotarget has also enhanced its frequency of publication to weekly.
Read more: Like
The journal has an editorial board made of experienced editors and professionals in the medical field. Mikhail Blagosklonny and Andrei Gudkov are the editors-in-chief of the magazine. Other members of the board are Cory Abate-Shen, Federick Alt, Jiri Bartek, Dafna Bar-Sagi, Carlo M. Croce, Kenneth Cowan, Brian j. Druker, and Stephen Saylin. These editors are mainly professors from various universities in the United States. The board members have also won numerous awards such as the Lasker Award, which was recently won by two editors, William G. Kaelin and Gregg L. Semenza. This award was given in recognition of the scientists’ work of discovering oxygen-sensing pathway. Semenza has published seven of the 370 oxygen related publications on Oncotarget.
Oncotarget has announced that it will offer Free Altmetric Article reports. They will help individuals to track performance of their works in real time. This form of tracking will be a milestone from the traditional methods that often needed lots of time to generate reports. Oncotarget has also adopted online submission of papers to ensure that researchers from all over the United States can submit their papers for reviewing and publications. The journal’s offices are based in Orchard Park, New York.